FASLODEX

This page contains recent news articles, when available, and an overview of FASLODEX but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.

Overview:

FASLODEX (when available)

Pharmacology and use:
Not Available For the treatment of hormone receptor positive metastatic breast cancer in postmenopausal women with disease progression following antiestrogen therapy.

Mechanism Of Action:
Not Available

News Articles on Fulvestrant

Lombardi researchers find investigational agent reduces tumor resistance to ...  -  05 Jan 2010
The investigational agent they used renews the sensitivity of these breast cancer cells to treatment by fulvestrant (Faslodex®) which had stopped working. ... EurekAlert (press release)

AstraZeneca's Phase III Cancer Drug Faslodex Study Shows Positive Results - Update  -  ‎Dec 10, 2009‎
The study showed that Faslodex, or fulvestrant 500 mg, reduced the risk of disease progression compared with Faslodex 250 mg, the dose currently approved by ... RTT News

Higher Dose of Faslodex® May Delay Breast Cancer Progression  -  ‎Dec 15, 2009‎
Researchers affiliated with the CONFIRM (Comparison of Fulvestrant in Recurrent or Metastatic Breast Cancer) trial have reported that high-dose Faslodex® ... Cancer Consultants

New Drugs, New Combinations Fight Breast Cancer  -  ‎Dec 11, 2009‎
One study found that a higher (500-milligram) dose of Faslodex (fulvestrant) works better than the currently approved 250-milligram dose in hormone ... U.S. News & World Report

UK Stocks -- Factors to watch on Dec 11  -  ‎Dec 10, 2009‎
...[ID:nGEE5B92I2] The drugmaker gives positive late-stage results from Faslodex 500 mg study. [ID:nWNBB0300] The world No. 2 iron ore miner has named a new ... Reuters

SABCS: Higher Dose of Fulvestrant Slows Breast Cancer  -  ‎Dec 14, 2009‎
...in time to progression when treated with 500 mg of fulvestrant (Faslodex) -- double the usual dose -- data from a multinational Phase III trial showed. ... MedPage Today

CTRC-AACR San Antonio Breast Cancer Symposium presents new data on emerging ...  -  ‎Dec 14, 2009‎
Fulvestrant, sold under the trade name Faslodex by AstraZeneca, is an estrogen receptor antagonist used for the treatment of metastatic receptor-positive ... News-Medical.net

Faslodex Dosis Tinggi Minimalisir Kanker Payudara  -  ‎Dec 20, 2009‎
Sebuah studi yang dipresentasikan di simposium tahunan San Antonio Breast Cancer di San Fransisko, Texas, menemukan bahwa Faslodex (fulvestrant) dalam dosis ... Media Indonesia

패스로�?�스 고용량 저용량 보다 효과�?  -  ‎Dec 12, 2009‎
...주민우 기�? [헬스코리아뉴스] 아스트�?�제네카�?� '패스로�?�스(Faslodex)' 500mg�?� 현재 승�?��?� 유통�?�고 있는 250mg보다 전�?�성 유방암�? �?�욱 효과�?�?��?�는 주장�?� ... 헬스코리아뉴스

NYA DATA VISAR BÄTTRE EFFEKT UTAN FLER BIVERKNINGAR VID SPRIDD BRÖSTCANCER  -  ‎Dec 10, 2009‎
Resultaten visar att en utökad dos, 500 mg, av Faslodex (fulvestrant) ger signifikant bättre progressionsfri överlevnad jämfört med den nu godkända dosen ... MyNewsdesk (pressmeddelande)

アストラゼ�?カ�?進行�?発乳�?�ん�?�フルベストラント用�?を５�?�?�?ｇ�?�増�?�?�る�?� ...  -  ‎Dec 11, 2009‎
...�?�閉経後ホルモン感�?�性進行�?発乳�?�ん患者を対象�?��?��?�第ＩＩＩ相臨床試験ＣＯＮＦＩＲＭ（ＣＯ�?�?�?ｒｉｓ�?Ｎ �?ｆＦＡＳＬＯＤＥＸＩｎＲｅｃｕｒｒｅｎｔ ... 日本経済新聞 (プレスリリース)

Promising Drugs for Cervical Cancer  -  ‎Nov 9, 2009‎
So Chung and Lambert gave the mice either Faslodex, used to treat certain breast cancers, or Evista, used to treat osteoporosis and to reduce the risk of ... WebMD

AstraZeneca hands global oncology portfolio to Edelman  -  ‎Nov 4, 2009‎
The latest additions to its range are Faslodex and Iressa. The disease areas it specialises in are prostate cancer, breast cancer and lung cancer. ... PRWeek UK

Fármacos para cancro da mama podem vir a combater cancro do colo do útero  -  ‎Nov 11, 2009‎
O medicamento fulvestrant (Faslodex®) contra o cancro da mama eo raloxifeno (Evista®) contra o cancro da mama ea osteoporose foram dados a ratos ... POP - Portal de Oncologia Portugês

유방암 치료제 2종, �?�?경부암�?�?� 효과�?  -  ‎Nov 9, 2009‎
...�? 약물�?� 세�?��?서 �?스트로�?�?� 작용�?� 억제하는 약물로 풀베스트란트는 '파슬로�?�스(Faslodex)', 랄�?시펜�?� '�?비스타(Evista)'로 �?매�?�다. ... 데일리팜

… Time to Response With FASLODEX(R) (Fulvestrant) Injection …  -  Dec 10, 2005
SAN ANTONIO, Texas, Dec. 10 /PRNewswire-FirstCall/ -- An analysis of two Phase III studies evaluating time to response (TTR) with FASLODEX(R) (fulvestrant) ... RedOrbit

Blocking Estrogen May Stop Lung Cancer Growth  -  Feb 15, 2005
The study also showed that an antiestrogen drug called Faslodex (search), which is commonly used in breast cancer treatment, blocked estrogen's action on ... FOXNews

Good clinical results for AstraZeneca's Faslodex in treating dissemina...  -  Mar 1, 2006
Recent Phase II clinical studies have shown that AstraZeneca's anti-oestrogenic agent Faslodex reduces the development of breast cancer in postmenopausal ... Pay-Per-View - Dagens Industri - Factiva, from Dow Jones

New Faslodex(TM) (Fulvestrant) Data Fill 'Treatment Gap' for Women...  -  Dec 17, 2006
AstraZeneca (NYSE:AZN) today announced the first results from a major clinical trial, EFECT (Evaluation of Faslodex vs Exemestane Clinical Trial), ... ots.at

New cause of tamoxifen resistance in breast cancer cells discovered  -  Aug 12, 2007
...to endocrine or anti-hormonal therapies, such as Tamoxifen and Faslodex. ... breast cancer cells led to reduced sensitivity to Tamoxifen and Faslodex. ... Hindu

Breast-Cancer Patients Wrongly Diagnosed and Treated, WSJ Says  -  Jan 4, 2008
Genentech Inc.'s Herceptin, GlaxoSmithKline Plc's Tykerb, AstraZeneca Plc's Arimidex and Faslodex, and other drugs, the Wall Street Journal reported. ... Bloomberg

New Faslodex(TM) (fulvestrant) Data Fill 'treatment Gap' For Women...  -  Jan 1, 2007
AstraZeneca has announced the first results from a major clinical trial, EFECT (Evaluation of Faslodex vs Exemestane Clinical Trial), at the annual San ... Medical News Today - Medical News Today (press release)

AstraZeneca's Faslodex and Arimidex little different.(for the...  -  Dec 19, 2005
Analysis of two Phase III studies evaluating the time to response of Faslodex (fulvestrant) injection compared with Arimidex (anastrozole) given as oral ... Free with registration - Pharma Marketletter - AccessMyLibrary.com

Faslodex as advanced breast cancer drug.(AstraZeneca PLC)  -  Mar 13, 2006
Data from a Phase II study of Anglo-Swedish drugmaker AstraZeneca's anticancer drug Faslodex (fulvestrant), published in the March issue of the Journal of ... Free with registration - Pharma Marketletter - AccessMyLibrary.com

Breast Cancer; Data on FASLODEX Injection presented at symposium  -  Jan 10, 2005
2005 JAN 10 - (NewsRx.com & NewsRx.net) -- Important new data from two phase II studies evaluating FASLODEX (fulvestrant) Injection as treatment for ... Pay-Per-View - Clinical Oncology Week - Factiva, from Dow Jones

SABCS: Aromasin and Faslodex Found Equivalent in Advanced Breast …  -  Dec 16, 2006
By Michael Smith, Senior Staff Writer, MedPage Today. SAN ANTONIO, Dec. 16 -- For women whose advanced breast cancer progressed with non-steroidal aromatase ... MedPage Today

Wunderman wins AstraZeneca's Faslodex  -  Apr 19, 2007
Pharmaceuticals marketer AstraZeneca has tapped Wunderman New York to launch a consumer campaign for Faslodex, a later-stage breast cancer prescription drug ... DM News

Breast Cancer; Data on FASLODEX Injection presented at symposium  -  Jan 14, 2005
2005 JAN 14 - (NewsRx.com & NewsRx.net) -- Important new data from two phase II studies evaluating FASLODEX (fulvestrant) Injection as treatment for ... Pay-Per-View - Drug Week - Factiva, from Dow Jones

Aromasin® and Faslodex® Similarly Effective and Safe As Second-Line …  -  Dec 14, 2006
According to results recently presented at the 2006 San Antonio Breast Cancer Symposium (SABCS), Aromasin (exemestane) and Faslodex (fulvestrant) ... Cancer Consultants

Drugs Approved by Health Ministry to Help 340,000 Israelis  -  Dec 22, 2008
Among the drugs approved in the latest round of additions are Erbitux, a drug used to treat bowel cancer, Faslodex, used to treat breast cancer, Novorapid, ... Arutz Sheva

Media Release: AstraZeneca.  -  Oct 31, 2005
Notes to Editors 'Faslodex' is a trademark, the property of the AstraZeneca group ... 'Faslodex' is indicated for the treatment of postmenopausal women with ... Free with registration - Asia Africa Intelligence Wire - AccessMyLibrary.com

How Triple-Negative Breast Cancer Behaves and Looks  -  Aug 1, 2008
...(chemical name: anastrozole), Aromasin (chemical name: exemestane), Femara (chemical name: letrozole), and Faslodex (chemical name: fulvestrant). ... Breastcancer.org

Strong data for AstraZeneca's Faslodex.  -  Dec 25, 2006
Strong data for AstraZeneca's Faslodex. Anglo-Swedish drug major AstraZeneca says that the first results from the EFECT trial, presented at the annual San ... $9.94 - Pharma Marketletter - Alacra Store

… Time to Response With FASLODEX(R) (Fulvestrant) Injection …  -  Dec 10, 2005
Analysis Demonstrates Time to Response With FASLODEX(R) (Fulvestrant) Injection Comparable to Anastrozole for Postmenopausal Women With Metastatic Breast ... Pay-Per-View - PR Newswire - HighBeam Research

Strong data for AstraZeneca's Faslodex  -  Dec 18, 2006
Anglo-Swedish drug major AstraZeneca says that the first results from the EFECT trial, presented at the annual San Antonio Breast Cancer Symposium, Texas, ... Pay-Per-View - Pharma Marketletter - Factiva, from Dow Jones

Study shows Faslodex equivalent to Arimidex in breast cancer therapy.  -  Nov 14, 2005
Data presented at the European Cancer Convention in Paris, France, suggest that AstraZeneca's Faslodex (fulvestrant) works as rapidly and is better ... $4.95 - Pharma Marketletter - ECNext

… Regulatory Review Period for Purposes of Patent Extension; FASLODEX...  -  Apr 24, 2006
The document announced that FDA had determined the regulatory review period for FASLODEX. A request for revision of regulatory review period was filed for ... Pay-Per-View - Federal Register - Factiva, from Dow Jones

Recent oncology R&D advances and Big Pharma's competitive struggle: …  -  May 2, 2005
This indicates that a competitive situation is imminent, as Pfizer's Aromasin (exemestane) and AstraZeneca's Faslodex (fulvastrant) both block the effects ... $4.95 - Pharma Marketletter - ECNext

유방암치료제 '파슬로�?�스' 국내 허가  -  Oct 26, 2007
EFFECT(Evaluation of Faslodex vs Exemestane Clinical Trial) 연구�?서 �?�전�? 호르몬 치료를 받고 질병�?� 진행�?� 여성�?게 파슬로�?�스로 치료한 결과 35.1%�?� 환�? ... 머니투�?��?�

[쿠키뉴스] 갓 구워낸 바삭바삭한 뉴스  -  Oct 30, 2008
...한국아스트�?�제네카�?� 파슬로�?�스(Faslodex)는 �?스트로�? 수용체 양성�?� �??경기 ... EFECT(Evaluation of Faslodex vs Exemestane Clinical Trial) 연구�?서 �?�전�? ... 쿠키뉴스

Empresas.- 'Faslodex' (AstraZeneca) en dosis altas controla mejor del...  -  Dec 15, 2008
Nuevos datos demuestran por primera vez que fulvestrant, comercializado por AstraZeneca como 'Faslodex' a dosis altas --de 500 miligramos--, ofrece mejor ... ecodiario

Fulvestrant (Faslodex)  -  Oct 20, 2007
Statens legmiddelverk har innvilge generell refusjon for Faslodex (fulvestrant) på blå resept fra 1.juli. Fulvestrant er en ny østrogenreseptorantagonist ... Statens legemiddelverk

阿斯利康公布2004年第一季度业绩报告  -  Nov 15, 2005
...信必�?�销售增长31%，达1亿8�?�8百万美元。肿瘤产�?表现强劲，增长19%。易瑞沙第一季度销售达9�?�3百万美元。瑞�?得销售增长62%。 Faslodex在欧盟注册批准用于晚期肺癌治疗。新浪网

The good rats: the women of my generation see cancer not as a death …  -  Jun 1, 2005
If Faslodex proved more beneficial, it would be considered by the US Food and Drug Administration ... Naturally, Bitsy wondered if she was getting Faslodex. ... $4.95 - Texas Monthly - ECNext

AstraZeneca: Bröstcancermarknad minst 10 Mdr kr/år - IC  -  Sep 15, 2006
..."Vi har faktiskt en produkt idag som heter Faslodex som har en likartad verkningsmekanism, men man hoppas att den här substansen, som vi då utvecklar ... Affärsvärlden - Affärsvärlden

Female non-smokers suffer disproportionately  -  Mar 8, 2006
She and Schiller are involved in research looking at whether Faslodex, an anti-estrogen drug used to treat metastatic breast cancers that contain estrogen ... Pay-Per-View - USA TODAY - ProQuest Archiver

Research and Markets: Providing Update Information on the Most Recent...  -  Apr 27, 2005
Two of the drugs, Aromasin and Faslodex both block the effects of the ... A potential threat for Aromasin is AstraZenecas drug Faslodex, which has been ... RedOrbit

全�?�女性相关�?�物市场分�?  -  Jan 24, 2007
...除了他莫昔芬和阿那曲唑，阿斯利康公�?��?��?��?�推出了氟维�?�群（Faslodex，fulvestrant）。Faslodex 是一�?抗雌激素�?�物（雌激素�?�体拮抗剂），被批准用于治疗激素�?�体 ... 金�?界

Three-Million Women in the US Are Living With Breast Cancer  -  Apr 13, 2007
Faslodex increased (+39%) to $140 million whereas Nolvadex decreased (-16%) to $114 million. Novartis reported that Femara increased it sell value by +30% ... webwire.com

Godt nyt til brystkræftpatienter  -  Aug 28, 2006
En månedlig indsprøjtning med medicinen Faslodex kan måske derfor hjælpe flere ... Faslodex kan være redningen, der stopper den katastrofale udvikling og ... Oestrogen.dk

Overall, Approximately 3 Million Women in The US Are Living with...  -  Apr 12, 2007
Faslodex increased (+39%) to $140 million whereas Nolvadex decreased (-16%) to $114 million. Novartis reported that Femara increased it sell value by +30% ... Genetic Engineering News - Genetic Engineering News (press release)

Best individual product advertisement in professional press.(Creative)...  -  Nov 1, 2008
..."Most breast cancer education in the past has focused on ... recurrence." AstraZeneca markets the breast cancer medications Faslodex, Nolvadex and ... ... Pay-Per-View - Medical Marketing & Media - HighBeam Research

Best use of PR to consumers.(Public Relations) | Article from Medical...  -  Nov 1, 2008
Most breast cancer education in the past has focused on ... recurrence. AstraZeneca markets the breast cancer medications Faslodex, Nolvadex and ... ... Pay-Per-View - Medical Marketing & Media - HighBeam Research

The AstraZeneca Scandal: Dear Feds  -  Apr 13, 2007
...which allegedly refer to an effort by one or more managers to promote off-label use for Faslodex and a tactical strike against a rival drug, ... Pharmalot

Press Release: Newly Published Study Reveals Femara(R) Improves …  -  Apr 30, 2007
FASLODEX in 67 postmenopausal women with advanced breast cancer who had previously ... Article: Analysis Demonstrates Time to Response With FASLODEX(R) ... ... Pay-Per-View - PR Newswire - HighBeam Research

'Zoladex(R)' (Goserelin) Adjuvant to Radiotherapy Found to Extend...  -  Apr 4, 2005
...'Zoladex', 'Arimidex', 'Casodex', 'Faslodex', 'Nolvadex' and 'Iressa' are trademarks of the AstraZeneca group of companies. [1] Pilepich MV, Winter K, ... RedOrbit

Sanofi corrals stars for cancer awareness effort.(PUBLIC RELATIONS) |...  -  Nov 1, 2007
..."Most breast cancer education in the past has focused on ... recurrence." AstraZeneca markets the breast cancer medications Faslodex, Nolvadex and ... ... Pay-Per-View - Medical Marketing & Media - HighBeam Research

Behandlung metast.BK in Thirdline?  -  Aug 1, 2008
...noch infrage kommen, d. heisst noch Wirkung zeigen, oder sollte gleich mit Faslodex angefangen werden? Meine Onkologin tendiert zunächst zu Faslodex. ... Onmeda

AstraZeneca Receive Highly Coveted Frost & Sullivan Award: ' …  -  Sep 20, 2005
...'ARIMIDEX', 'CASODEX', 'FASLODEX', 'NOLVADEX', 'ZOLADEX', 'TOMUDEX', and 'IRESSA' are trademarks, the property of the AstraZeneca group of companies. ... RedOrbit

Female non-smokers suffer disproportionately  -  Mar 7, 2006
She and Schiller are involved in research looking at whether Faslodex, an anti-estrogen drug used to treat metastatic breast cancers that contain estrogen ... USA Today

Breast Cancer Hormone Therapy - Breast Cancer Health Information - NY...  -  Nov 10, 2008
A third drug, fulvestrant (Faslodex), works in a similar anti-estrogen way to tamoxifen but belongs to a different drug class. Fulvestrant is approved only ... New York Times

New International Treatment Guidelines Verify Crucial Role of 'Arimide...  -  Jul 9, 2005
...'ARIMIDEX', 'CASODEX', 'FASLODEX', 'NOLVADEX', 'ZOLADEX', 'TOMUDEX', and 'IRESSA' are trademarks, the property of the AstraZeneca group of companies. presseportal.de

Persons of the Week: Cancer Survivors  -  Sep 5, 2008
But right now her doctors at Memorial Sloan Kettering Cancer Center in New York are giving her a hormone therapy, Faslodex, and a targeted therapy called ... ABC News

Tarptautinėje konferencijoje - nauji vėžio gydymo metodai  -  Oct 17, 2005
Specialistų teigimu, naujo tipo endokrininis preparatas "Faslodex" preparatas veikia išplitusį, hormonams jautrų krūties vėžį, kai gydymas tamoksifenu ... Sekundė.lt

'Zoladex(R)' (Goserelin) Adjuvant to Radiotherapy Found to Extend...  -  Apr 3, 2005
...'Zoladex', 'Arimidex', 'Casodex', 'Faslodex', 'Nolvadex' and 'Iressa' are trademarks of the AstraZeneca group of companies. [1] Pilepich MV, Winter K, ... $4.95 - PR Newswire - ECNext

Clinical trials catalyst for market shift.  -  Jul 6, 2005
5% to the anti-estrogens and 2% to other hormone antagonists- currently containing only one product: AstraZeneca's Faslodex (fulvestrant). ... $4.95 - M2 Presswire - ECNext

Tumore mammario avanzato: benefici dell'opzione endocrina dopo …  -  Jan 10, 2007
Mercoledì 10 Gennaio 2007 - Uno studio di fase III, EFECT ( Evaluation of Faslodex vs Exemestane Clinical Trial ), ha valutato Fulvestrant ( Faslodex ) ... XagenaSalute

Breast Cancer; Researchers report details of new studies and findings...  -  Nov 15, 2005
Bundred's paper appeared in Cancer Investigation (Preclinical and clinical experience with fulvestrant (Faslodex) in postmenopausal women with hormone ... Pay-Per-View - Life Science Weekly - Factiva, from Dow Jones

AstraZeneca site extends breast cancer message.(Brief Article) |...  -  Nov 1, 2005
AstraZeneca markets the breast cancer medications Faslodex, Nolvadex and Arimidex in the U.S., and the company is the founder and sole funder of National ... Pay-Per-View - Medical Marketing & Media - HighBeam Research

Breast Cancer; Researchers' work adds to breast cancer body of …  -  Nov 1, 2005
Bundred's paper appeared in Cancer Investigation (Preclinical and clinical experience with fulvestrant (Faslodex) in postmenopausal women with hormone ... Pay-Per-View - Life Science Weekly - Factiva, from Dow Jones

Factiva Search  -  Jan 10, 2005
Breast Cancer; Data on FASLODEX Injection presented at symposium. 10 January, 2005 OBGYN & Reproduction Week. 2005 JAN 10 - (NewsRx.com & NewsRx.net) ... Pay-Per-View - OBGYN & Reproduction Week - Factiva, from Dow Jones

Factiva Search  -  Jan 10, 2005
Breast Cancer; Data on FASLODEX Injection presented at symposium. 10 January, 2005 Health & Medicine Week. 2005 JAN 10 - (NewsRx.com & NewsRx.net) ... Pay-Per-View - Health & Medicine Week - Factiva, from Dow Jones

Factiva Search  -  Jan 10, 2005
Breast Cancer; Data on FASLODEX Injection presented at symposium. 10 January, 2005 Pharma Business Week. 2005 JAN 10 - (NewsRx.com & NewsRx.net) ... Pay-Per-View - Pharma Business Week - Factiva, from Dow Jones

Factiva Search  -  Jan 11, 2005
Breast Cancer; Data on FASLODEX Injection presented at symposium. 11 January, 2005 Life Science Weekly. 2005 JAN 11 - (NewsRx.com & NewsRx.net) -- Important ... Pay-Per-View - Life Science Weekly - Factiva, from Dow Jones

Article: CONGRATS GRAMPS..YOU'RE A MUM.(Features) - Sunday Mail …  -  Sep 28, 2008
Article: FASLODEX AS EFFECTIVE AS ARIMIDEX IN ADVANCED BREAST CANCER. AsiaPulse News; December 8, 2003 ; 700+ words ... ... following prior anti-estrogen ... Pay-Per-View - Sunday Mail - HighBeam Research

Press Release: Y-ME Makes Historic Announcement on Mother's Day. - …  -  May 11, 2008
Article: FASLODEX(R) (Fulvestrant) Added to Nationally Recognized ... PR Newswire; April 24, ... FASLODEX ... Comprehensive Cancer Network (JNCCN . ... Pay-Per-View - PR Newswire - HighBeam Research

AstraZeneca actions under US review.  -  May 3, 2007
...that managers like Zubillaga had been pushing sales representatives to make unfounded and improper pitches for cancer drugs Arimidex and Faslodex. ... Free with registration - Philadelphia Inquirer - AccessMyLibrary.com

Article: Chemo Is Praised for Hard-To-Treat Cancer - AP Online | …  -  Apr 11, 2006
Article: FASLODEX(R) (Fulvestrant) Added to Nationally Recognized ... ... FASLODEX ... Journal of the National Comprehensive Cancer Network . ... Pay-Per-View - AP Online - HighBeam Research

Press Release: 30th Anniversary Gala Raises $900,000 for Breast …  -  Oct 20, 2008
Article: FASLODEX(R) (Fulvestrant) Added to Nationally Recognized ... PR Newswire; April 24, ... FASLODEX ... Comprehensive Cancer Network (JNCCN . ... Pay-Per-View - PR Newswire - HighBeam Research

On the Mend at AstraZeneca  -  Aug 9, 2005
Key new drugs include Exanta, an oral anticoagulant used to prevent blood clots; Galida for diabetes; Faslodex, an anticancer drug; Cerovive for strokes; ... BusinessWeek

Article: 32. Additional therapy with mistletoe extracts in breast...  -  Oct 1, 2007
Article: New Clinical Trial of FASLODEX(R) (Fulvestrant) Seeks to Identify . ... FASLODEX in patients with advanced breast cancer whose disease has recurred ... Pay-Per-View - Phytomedicine: International Journal of... - HighBeam Research

Press Release: MultiVu Video Feed: Older Does Not Always Mean Wiser: ...  -  Jul 26, 2006
Article: New Data Reported on FASLODEX(R) (Fulvestrant) Injection in ... ... FASLODEX in 67 postmenopausal women with advanced breast cancer who had ... Pay-Per-View - PR Newswire - HighBeam Research

Press Release: BOOMj, Inc. Joins Fight Against Breast Cancer. - PR …  -  Oct 7, 2008
Article: FASLODEX(R) (Fulvestrant) Added to Nationally Recognized ... PR Newswire; April 24, ... FASLODEX ... Comprehensive Cancer Network (JNCCN . ... Pay-Per-View - PR Newswire - HighBeam Research

Article: INSPIRATIONAL CLIMB JOIN STARS IN HIKE FOR BREAST- …  -  Oct 8, 2007
Article: FASLODEX(R) (Fulvestrant) Added to Nationally Recognized ... ... FASLODEX ... the National Comprehensive Cancer Network (JNCCN . ... Pay-Per-View - Daily News - HighBeam Research

Press Release: UK Leads Europe and US in Milestone Post-op Breast …  -  Dec 8, 2005
Article: New Data Reported on FASLODEX(R) (Fulvestrant) Injection in ... ... FASLODEX in 67 postmenopausal women with advanced breast cancer who had ... Pay-Per-View - PR Newswire - HighBeam Research

Article: PINK BICYCLE RACK SALES AID BREAST CANCER FIGHT.( …  -  Oct 1, 2007
Article: FASLODEX(R) (Fulvestrant) Added to Nationally Recognized ... ... FASLODEX ... the National Comprehensive Cancer Network (JNCCN . ... Pay-Per-View - Wisconsin State Journal - HighBeam Research

Cancer patients laud Edwards  -  Mar 29, 2007
...regimen of medicine: Zometa to rebuild bones; Herceptin, to stop estrogen from feeding cancer cells; and Faslodex, to boost the power of the Herceptin. ... Rocky Mountain News

Herbal hope in breast cancer battle  -  Nov 2, 2005
It also enhances anti-oestrogen drugs such as tamoxifen and Faslodex. Other herbal sources of GLA besides evening primrose oil include borage oil and black ... Scotsman

Evening primrose oil could help beat breast cancer  -  Nov 3, 2005
It also enhances anti-oestrogen drugs such as tamoxifen and Faslodex. One reason for this wide ranging effect could be GLA's influence on Her-2/neu. ... Daily Mail

Clues to why Tamoxifen does not work for some women  -  Feb 18, 2005
...is doing the research, has identified 168 genes involved in Tamoxifen resistance and 141 associated with resistance to a similar drug called Faslodex.. ... WalesOnline

WHAT'S NEW IN CANCER CARE  -  Sep 29, 2005
Faslodex, a drug in the same family, is now used as a back-up for advanced cancer in those patients who have become resistant to tamoxifen. ... Mirror.co.uk

AstraZeneca actions under US review. | Article from Philadelphia...  -  May 3, 2007
...that managers like Zubillaga had been pushing sales representatives to make unfounded and improper pitches for cancer drugs Arimidex and Faslodex. ... Pay-Per-View - Philadelphia Inquirer - HighBeam Research

Why does lung cancer acts differently in women and men?  -  May 29, 2006
Los Angeles, will test whether women fare better when given the anti-estrogen drug Faslodex on top of the lung cancer drug Tarceva. ... Free with registration - America's Intelligence Wire - AccessMyLibrary.com

Article: Cancer patients laud Edwards Plan to continue with campaign ...  -  Mar 29, 2007
...regimen of medicine: Zometa to rebuild bones; Herceptin, to stop estrogen from feeding cancer cells; and Faslodex, to boost the power of the Herceptin. ... Pay-Per-View - Rocky Mountain News - HighBeam Research

Estrogen Plays a Role in Prostate Cancer  -  May 29, 2008
The estrogen-receptor antagonist fulvestrant (Faslodex) also reduced TMPRSS2-ERG expression (0.58-fold increase compared with one-fold increase with control ... MedPage Today

Surgery, radiation, chemo, recombinant antibody combat breast cancer;...  -  Mar 1, 2005
1x/d Letrozole-- Femara (Novartis) Depletes estrogen 2.5 mg PO 1x/d Antiestrogens Fulvestrant-- Faslodex (AstraZeneca) Degrades receptor 250 mg IM 1x/mo ... Free with registration - Managed Healthcare Executive - AccessMyLibrary.com

당신�?� 건강가�?�드 헬스조선  -  Mar 10, 2006
...아로마타제 억제제'로 치료를 받았는�?��?� 유방암�?� 진행�?� �??경 후 여성�?게 아스트�?� 제네카�?� '파슬로�?�스(Faslodex)'가 항종양 효과를 나타낸다고 발표했다. ... 뉴스플러스

Analysis: Stopping breast-cancer return.  -  Dec 19, 2006
...sold as Faslodex, appeared as efficacious as the daily oral aromatase inhibitor exemestane, marketed as Aromasin, in women battling the disease. ... Free with registration - UPI Health Business - AccessMyLibrary.com

Especialistas debatem novas armas contra câncer de mama  -  Feb 5, 2007
CONFIRMAÇÃO Outro medicamento apresentado em San Antonio foi o Faslodex, do laboratório AstraZeneca. Ele é da classe de antiestrogênios e mostrou desempenho ... Último Segundo

Valkuil van nieuw borstkankermedicijn  -  Jan 23, 2007
...als anti-hormoontherapie nooit alleen aromataseremmers te krijgen. Bekende aromotaseremmers zijn Femara - Letrozole, Anastrazole, Faslodex, en Exemestaan. Stentor

阿斯利康的研�?�中心  -  Jul 21, 2005
Alderley Park研制出的新�?�包括康士得®�?瑞�?得®�?Faslodex®和抗肿瘤新�?�易瑞沙®。 2003年6月，我们在�?�度�?�加洛尔的新实验室正�?投入使用，主�?研究结核病的新疗法。 ... �?��?

סל הברי�?ות הב�?: 181 תרופות חדשות  -  Jan 31, 2005
...faslodex - טיפול משלי�? קו שני �?ו שלישי בסרטן השד, arimidex - טיפול משלי�? קו ר�?שון לסרטן השד, ... NRG מעריב

SABCS: Estradiol May Restore Breast Tumor Sensitivity to Aromatase …  -  Dec 12, 2008
The patient has since responded to treatment with fulvestrant (Faslodex). The second patient had stable disease for 38 weeks with low-dose estradiol and ... MedPage Today

Antidepressants May Alter Levels of Tamoxifen in the Body  -  Jan 4, 2005
Doctors hope to use the information to develop tests that can help them predict which drug -- tamoxifen, an aromatase inhibitor, or Faslodex, for instance ... ACS News Center

Lung Cancer's Gender Differences Under Study  -  May 31, 2006
University of California, Los Angeles, will test whether women fare better given the anti-estrogen drug Faslodex on top of the lung cancer drug Tarceva. ... HealthCentral.com

Celtic Pharma Appoints Two New Senior Executives  -  Nov 21, 2006
...including Zoladex, Casodex, Arimidex, Tomudex and Faslodex, as well as leading the Phase III program for the novel antipsychotic, Seroquel. ... RedOrbit

Sarah Cannon Research Institute to Present New Trial Results at San …  -  Dec 10, 2008
...of Avastin combined with hormonal therapies consisting of either Arimidex or Faslodex; and the drug Javlor by itself and in combination with Herceptin. ... International Business Times

AZ calls in Tonic for prostate job  -  Feb 4, 2005
...media relations for the brand (PRWeek, 28 January). SHI continues to handle global communications for other AZ cancer brands, such as Faslodex and Arimidex. PRWeek UK

Becoming author after brest cancer  -  Oct 5, 2006
I stayed on that for over a year and then after my cancer markers were back to normal I went back on the hormonal drugs, Femora and Faslodex. ... TopCancerNews.com

ASIANET DAILY SUMMARY - NOV 1, 2005.  -  Nov 1, 2005
MACCLESFIELD: New data presented at The European Cancer Congress, Paris, shows 'Faslodex' (fulvestrant) works as quickly as the gold-standard Arimidex ... Free with registration - Asia Africa Intelligence Wire - AccessMyLibrary.com

ASIANET DAILY SUMMARY - NOV 1, 2005.  -  Nov 1, 2005
MACCLESFIELD: New data presented at The European Cancer Congress, Paris, shows 'Faslodex' (fulvestrant) works as quickly as the gold-standard Arimidex ... Free with registration - AsiaPulse News - AccessMyLibrary.com

Blocking Estrogen Critical to Lung Cancer Survival?  -  Feb 22, 2005
They studied the effectiveness of an estrogen receptor-blocking drug (fulvestrant, also known as Faslodex), an epidermal growth factor receptor-blocking ... Ivanhoe Broadcast News

Resolute snaps up Lowe's Jones  -  Jan 7, 2005
Jones worked at Lowe Fusion, where she promoted AstraZeneca's breast-cancer drug Faslodex, for just over two and a half years. PRWeek UK

Fulvestrant, Exemestane Show Equivalent Survival in Relapsed …  -  Dec 16, 2007
Funding for the EFECT study was provided by AstraZeneca, which markets fulvestrant under the trade name Faslodex. [Presentation title: Fulvestrant vs ... DG News

Shire Health poaches AZ's Wright  -  Jan 14, 2005
Shire Health London sister company Shire Health International promotes Arimidex and Faslodex (breast cancer) brands globally. ... PRWeek UK

Brand Names/Synonyms:
FASLODEX is also known by the following brand names and/or synonymsFaslodex; Fulvestrant; Fulvestrant [Usan]

Drug Category:
FASLODEX is categorized under the following by the FDA: Antineoplastic Agents; Antineoplastic Agents; ATC:L02BA03

Dosage Forms:
SOLUTION

Absorption:
Not Available

Interactions:
[an error occurred while processing this directive]

Chemical IUPAC Name:
13-methyl-7-[9-(4,4,5,5,5-pentafluoropentylsulfinyl)nonyl]-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthrene-3,17-diol

Disclaimer:

Contact a physician with regard to health concerns. Email requests for further health information will be discarded.

The materials contained on this Web site are for informational purposes only and do not constitute health or medical advice. Use of information on this site does not create or constitute any kind of agreement or contract between you and the owners or users of this site, the owners of the servers upon which it is housed, or anyone else who is in any way connected with this site.

Many links on cancernewsnetwork.org lead to other sites. cancernewsnetwork.org does not sponsor, endorse or otherwise approve of the materials appearing in such sites. Nor is CancerNewsNetwork.org responsible for dead or misdirected links.

IF YOU NEED A LINK OR TEXT REMOVED FROM THIS PAGE PLEASE CONTACT cancernewsnetwork (at) live.com.
We will do our best to accommodate your request.